The COVID-19 ICU PRAYER Study
NCT04361838 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2022-02-03
Summary
This is a multicenter; double blind randomized controlled study investigating the role of remote intercessory multi-denominational prayer on clinical outcomes in COVID-19 + patients in the intensive care unit. All patients enrolled will be randomized to use of prayer vs. no prayer in a 1:1 ratio. Each patient randomized to the prayer arm will receive a "universal" prayer offered by 5 religious denominations (Christianity, Hinduism, Islam, Judaism and Buddhism) in addition to standard of care. Whereas the patients randomized to the control arm will receive standard of care outlined by their medical teams. During ICU stay, patients will have serial assessment of multi-organ function and APACHE-II/SOFA scores serial evaluation performed on a daily basis until discharge. Data assessed include those listed below.
Conditions
- Coronavirus Infection
Interventions
- BEHAVIORAL
-
prayer
receive prayers daily while in ICU
Sponsors & Collaborators
-
Kansas City Heart Rhythm Institute
lead OTHER
Principal Investigators
-
Dhanunjaya Lakkireddy, MD · Kansas City Heart Rhythm Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-21
- Primary Completion
- 2021-04-30
- Completion
- 2021-04-30
Countries
- United States
Study Locations
More Related Trials
-
Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit
NCT00549393 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
NO Prevention of COVID-19 for Healthcare Providers
NCT04312243 ·Status: TERMINATED ·Phase: PHASE2
-
Oral Care to Reduce Mouth and Throat Infections in Critically Ill Patients
NCT00078663 ·Status: COMPLETED ·Phase: PHASE3
-
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19
NCT04567173 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%
NCT03442023 ·Status: UNKNOWN ·Phase: PHASE3
-
Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19
NCT04358211 ·Status: NO_LONGER_AVAILABLE
-
Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2
NCT04665960 ·Status: COMPLETED
-
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches
NCT04410263 ·Status: UNKNOWN
-
NOSOcomial COVID-19 in ICU (NOSOCOVID)
NCT04659356 ·Status: UNKNOWN
-
Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients
NCT06080737 ·Status: COMPLETED
-
Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients
NCT00543894 ·Status: COMPLETED
-
Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome
NCT04380935 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of the Effectiveness of Daily Pulse Lavage Therapy in Chronic Wounds
NCT01500746 ·Status: COMPLETED ·Phase: NA
-
COVID-19 With Convalescent Plasma
NCT04616976 ·Status: COMPLETED
-
Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit
NCT04355481 ·Status: UNKNOWN
-
How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?
NCT04348227 ·Status: UNKNOWN
-
Comparison of Clinical Outcome Among Vaccinated and Unvaccinated Coronavirus Disease Patients in Critical Care Unit.
NCT05331742 ·Status: UNKNOWN
-
Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica
NCT04644198 ·Status: UNKNOWN ·Phase: PHASE2
-
Antibiograms of Intensive Care Units at an Egyptian Tertiary Care Hospital
NCT04318613 ·Status: COMPLETED
-
Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43
NCT01563263 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
NCT05485051 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Analysis of Tigecycline-based Therapy and Polymyxin B-based Therapy in ICU Infection
NCT04970537 ·Status: UNKNOWN
-
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment
NCT04416919 ·Status: COMPLETED ·Phase: NA
-
Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia
NCT02728518 ·Status: COMPLETED ·Phase: NA
-
Topical Application of Silver Nanoparticles and Oral Pathogens in Ill Patients
NCT02761525 ·Status: COMPLETED ·Phase: NA